0756 GMT - Roche delivered solid results in line with expectations but its diagnostics' profitability disappoints, Vontobel analyst Stefan Schneider says in a note. The Swiss pharma giant's core EBIT of its diagnostics unit missed Vontobel's estimates by 10.5% which surprises as only 1Q was still affected by the pandemic washout, the analyst says. Its 2025 guidance is conservative, unchanged under the new management, he adds. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
January 30, 2025 02:56 ET (07:56 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。